Kintara Therapeutics : Shareholder Meeting - Form 8-K

Item 5.08 Shareholder Director Nominations

On May 5, 2024, Kintara Therapeutics, Inc. (the "Company") scheduled its 2024 annual meeting of stockholders (the "2024 Annual Meeting") to be held via the Internet, on June 20, 2024, at 12:00 p.m., Eastern time and established May 9, 2024, as the record date for determining stockholders entitled to notice of, and to vote at, the 2024 Annual Meeting.

Because the date of the 2024 Annual Meeting will be more than 30 days from the anniversary of the Company's 2023 annual meeting of stockholders, the deadline for submission of proposals by stockholders for inclusion in the Company's proxy materials in accordance with Rule 14a-8 under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), will be the close of business on May 16, 2024, which the Company has determined to be a reasonable time before it expects to begin to print and distribute its proxy materials prior to the 2024 Annual Meeting. Any such proposal must also meet the requirements set forth in the rules and regulations of the Exchange Act in order to be eligible for inclusion in the proxy materials for the 2024 Annual Meeting.

In accordance with the Company's Amended and Restated Bylaws (the "Bylaws"), any stockholder who intends to nominate a person for election as a director or submit a proposal for inclusion at our 2024 Annual Meeting must provide notice ("Stockholder Notice") on or before May 19, 2024. Any Stockholder Notice must comply with the specific requirements set forth in the Bylaws in order to be considered at the 2024 Annual Meeting. Any such proposal shall be mailed to: Kintara Therapeutics, Inc., 9920 Pacific Heights Blvd, Suite 150 San Diego, CA 92121, Attn.: Secretary, or at [phone].